Epsilon Health

Epsilon Health

Epsilon Health was established to back entrepreneurs modernizing the technology stack underneath American and European healthcare. The firm operates from multiple offices in California and Massachusetts, with an additional engineering-oriented outpost in Thessaloniki, Greece — a structure that reflects its conviction that healthcare innovation increasingly originates from academic medical centers and technical universities outside traditional biotech clusters. The firm concentrates on early-stage digital health and healthcare AI, writing initial checks at the seed and Series A stages. Its portfolio spans clinical workflow software, value-based care enablement, remote patient monitoring, and machine learning applications for diagnostics and drug development. Epsilon Health typically leads or co-leads rounds, reserving significant capital for follow-on investments through a company's growth phase. Confirmed investment areas include prior authorizations automation, interoperable data platforms connecting payers and providers, and AI-powered imaging analysis tools. The firm invests across North America and Western Europe, with particular attention to companies commercializing research from institutions in Boston, the Bay Area, and select European health systems. Epsilon Health maintains a compact team distributed across its US offices and its Thessaloniki engineering hub, which provides technical diligence capacity uncommon among healthcare-focused venture firms of its size. The firm co-invests alongside leading digital health specialists and generalist funds, acting as a syndicate partner on rounds where its sector expertise adds operational value to technical founders. Its multi-city footprint enables relationships with academic medical centers and health system innovation arms that serve as both design partners and eventual customers for its portfolio companies. Epsilon Health's structural distinction lies in its hybrid US-European presence and the integration of an in-house engineering team into its investment process. Unlike most digital health funds that rely entirely on outside experts for technical diligence, the firm uses its Thessaloniki office to evaluate the defensibility and scalability of portfolio companies' technology stacks before committing capital — an architecture designed to reduce technical due diligence risk in an asset class where product differentiation increasingly depends on proprietary data pipelines and machine learning models rather than sales execution alone.